Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Components of Accrued Liabilities (Detail)

v3.22.1
Balance Sheet Components - Components of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Accrued liabilities:    
General and administrative $ 1,160 $ 794
Clinical trial related costs 615 1,134
Non-clinical research and manufacturing operations 3,418 2,153
Payroll related 2,660 5,388
Other accrued expenses 52 46
Total Accrued liabilities $ 7,905 $ 9,515